Clinical Trial Update: Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the impact of carbidopa/levodopa/entacapone on quality of life in Parkinson's disease has completed and is not recruiting in the Unit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Novartis | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED